The Dermatologist is excited to publish this special issue, Psoriasis Treatment Today. It continues to be a ground-breaking time in the development of therapies to treat psoriasis and psoriatic arthritis. Psoriasis remains one of the most common chronic inflammatory skin diseases, with worldwide prevalence ranging from 0.5% to 11.4% in adults.
Harvey H. Jay, MD, in private practice in New York, NY, spoke with The Dermatologist about recent advances in the field, the psychosocial impact of rosacea, and how he uses intense pulse light (IPL) in his practice to treat patients with rosacea.
Dr Merola highlights the importance of the upcoming 2018 Interdisciplinary Autoimmune Summit to help clinicians navigate the increasing overlap and complexity between specialties with the pathophysiologic mechanisms of immunologic disease.
The Dermatologist spoke with Joel M. Gelfand, MD, MSCE, about his involvement with The 2018 Interdisciplinary Autoimmune Summit (IAS) meeting, the evolving landscape of psoriasis, and his outlook on the future of immune-mediated inflammatory diseases (IMIDs).